Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04577599 · ClinicalTrials.gov registry record · NA
Lung B.A.S.E.S. 4 Life Mobile Low-dose Computed Tomography (LDCT) Screening: Ages 40-54
A NA study of Lung Cancer and Lung Neoplasms, sponsored by Wake Forest University Health Sciences.
- Recruiting
- Registry status
- NA
- Development phase
- 1,160
- Enrollment target
- 1
- Study location
NCT04577599: Recruiting NA study of Lung Cancer and Lung Neoplasms, sponsored by Wake Forest University Health Sciences.
NCT04577599 is a NA study of Lung Cancer and Lung Neoplasms that is actively recruiting participants, run by Wake Forest University Health Sciences. The registered enrollment target is 1,160 participants, above the 933-participant average among 409 other Lung Cancer trials with a reported enrollment target (24% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04577599, a NA study of Lung Cancer and Lung Neoplasms, is actively recruiting participants, sponsored by Wake Forest University Health Sciences.
- RECRUITING
- Registry status
- NA
- Development phase
- 1,160 participants
- Enrollment target
- 1
- Study location
Study Summary
Low-dose CT Screening has been shown in two large trials in the United States (NLST) and Europe (NELSON) to increase overall survival in subjects 55 years of age and older with a strong smoking history. Unfortunately, in both North Carolina (NC) and South Carolina (SC), subjects are found to have the above referenced smoking history prior to reaching the minimum age in these studies. This study is aimed at decreasing the minimum age of screening in a high-risk population.
Primary Outcome
The lung cancer diagnosis variable will be determined for each subject as a binary variable indicating whether or not the subject's T0 screening results in a diagnosis of lung cancer.
Conditions Studied
Interventions
- OTHER Mobile Low-dose Computed Tomography (LDCT) Screening
Study Locations (1)
North Carolina
- Levine Cancer Institute - Charlotte
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,160 participants |
| Start Date | 2021-01-07 |
| Est. Completion | 2028-10 |
| Phase | NA |
What NCT04577599 shows while recruiting
NCT04577599 is an interventional study that assigns participants to a tested intervention. Its 1,160 participants enrollment target places it among the larger protocols in the corpus, above the 933-participant average among 409 other Lung Cancer trials with a reported enrollment target (24% higher).
The record links to 2 conditions, with Lung Cancer appearing as the primary indexed condition, and to 1 intervention - of which Mobile Low-dose Computed Tomography (LDCT) Screening is the first listed.
NCT04577599 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT04577599 about?
NCT04577599 is a clinical study titled "Lung B.A.S.E.S. 4 Life Mobile Low-dose Computed Tomography (LDCT) Screening: Ages 40-54". Low-dose CT Screening has been shown in two large trials in the United States (NLST) and Europe (NELSON) to increase overall survival in subjects 55 years of age and older with a strong smoking history. Unfortunately, in both North Carolina (NC) and South Carolina (SC), subjects are found to have th...
What is the current status of trial NCT04577599?
This trial is currently recruiting. It is a NA study. The enrollment target is 1,160 participants. The study started on 2021-01-07. Estimated completion is 2028-10.
What conditions does trial NCT04577599 study?
This clinical trial studies the following conditions: Lung Cancer, Lung Neoplasms.
What interventions are being tested in trial NCT04577599?
The interventions under investigation include: Mobile Low-dose Computed Tomography (LDCT) Screening (OTHER).
Who is sponsoring clinical trial NCT04577599?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04577599 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lung Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04577599's enrollment target sits among peer trials
1,160 43rd of 409 higher than 367 of 409 other Lung Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Lung Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Lung Cancer Screening in High-risk Black Individuals
RECRUITING · NA
-
A Patient and Provider Intervention to Address Health Disparities in Lung Cancer Screening
RECRUITING · NA
-
Exercise as Maintenance Therapy in Advanced Lung Cancer
RECRUITING · NA
-
Improving Care for Rural Patients With Solid Tumors
RECRUITING · NA
-
Stereotactic Magnetic Resonance Guided Radiation Therapy
RECRUITING · NA
-
Virtual Agent Feasibility in Oncology Patients (NTT Data)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07082738 · 1,160 participants · Phase 2
A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
- NCT07237048 · 1,164 participants · Phase 2
Minocycline in Stroke Study at Maimonides
- NCT07009509 · 1,166 participants · NA
Pilot Study of the YES-CAN! Program to Prevent Youth Nicotine Vaping
- NCT04474301 · 1,152 participants
Well-Being and Health-Related Quality of Life in Melanoma Patients During COVID-19 Pandemic
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI